Cited by 278Liver Disease Diagnosis and TreatmentPharmacology and Obesity TreatmentSeaweed-derived Bioactive Compounds

The effects of Xanthigen ™ in the weight management of obese premenopausal women with non‐alcoholic fatty liver disease and normal liver fat

Abidov, M., Ramazanov, Z., Seifulla, R., Grachev, S.·2010·Diabetes, Obesity and Metabolism

Abstract

Aim: To investigate the effects of Xanthigen (brown marine algae fucoxanthin + pomegranate seed oil (PSO)) on body weight, body fat, liver lipids, and blood biochemistry; and Xanthigen and its individual components on resting energy expenditure (REE) in obese, non‐diabetic female volunteers with non‐alcoholic fatty liver disease (NAFLD) and normal liver fat (NLF) content. Methods: Sixteen‐week, double‐blind, randomized, placebo‐controlled study. Food record data, body composition, REE (only 41 volunteers with NAFLD) and blood sample analysis were assessed weekly for 16 weeks in 151 non‐diabetic, obese premenopausal women with liver fat content above 11% (NAFLD) n = 113, and below 6.5% (NLF) n = 38. Results: Xanthigen‐600/2.4 mg (300 mg PSO + 300 mg brown seaweed extract containing 2.4 mg fucoxanthin) resulted in statistically significant reduction of body weight (5.5 ± 1.4 kg NAFLD group and 4.9 ± 1.2 kg NLF group, p < 0.05), waist circumference (NAFLD group only), body (3.5 ± 1.9 kg NAFLD group, p < 0.001; 3.6 ± 0.7 kg NLF group, p < 0.05) and liver fat content, liver enzymes (NAFLD group only), serum triglycerides and C‐reactive protein. Weight loss and reduction in body and liver fat content occurred earlier in patients with NLF than in patients with NAFLD. Fucoxanthin ( > 2.4 mg) and Xanthigen‐400/1.6 mg (200 mg PSO + 200 mg brown seaweed extract containing 1.6 mg fucoxanthin) significantly increased REE in NAFLD subjects compared to placebo. Conclusions: Xanthigen promoted weight loss, reduced body and liver fat content, and improved liver function tests in obese non‐diabetic women. Xanthigen and Fucoxanthin also increased REE. This product may be considered a promising food supplement in the management of obesity.

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2009.01132.x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abidov, M., Ramazanov, Z., Seifulla, R., & Grachev, S.
Affiliations
  • Russian Academy of Natural Sciences (RU)
  • Sechenov University (RU)
Corresponding author
Abidov, M.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2009-12-22
Volume
12
Issue
1
Pages
72-81
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2164271483
Cited by
278
References
39
Citations by year
2026: 13 · 2025: 9 · 2024: 12 · 2023: 17 · 2022: 17 · 2021: 32 · 2020: 29 · 2019: 19 · 2018: 22 · 2017: 19 · 2016: 20 · 2015: 21 · 2014: 10 · 2013: 15 · 2012: 12
FWCI
5.14
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Obesity and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
Keywords
fucoxanthin, pomegranate seed oil, brown seaweed extract, obesity, non-alcoholic fatty liver disease, weight loss, fat loss, liver fat, resting energy expenditure, premenopausal women, dietary supplements, serum triglycerides, C-reactive protein, liver enzymes
MeSH terms
Adult, Body Weight, Double-Blind Method, Drug Combinations, Energy Metabolism, Fatty Liver, Female, Humans, Obesity, Plant Oils, Weight Loss, Body Mass Index, Treatment Outcome, Premenopause, Anti-Obesity Agents, Xanthophylls

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review